<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04030494</url>
  </required_header>
  <id_info>
    <org_study_id>2018-A02847-48</org_study_id>
    <nct_id>NCT04030494</nct_id>
  </id_info>
  <brief_title>Validation Study of an Advanced Blood Pressure Monitor</brief_title>
  <acronym>TALISMAN</acronym>
  <official_title>Study of Validation of the Advanced Blood Pressure Monitor Withings WPM04 for the Detection of Anomalies of Arterial Pressure, Arrhythmia and Valvular Heart Diseases</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Withings</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Clinact</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Withings</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The proposed clinical study aims to validate the effectiveness of the WPM04 blood pressure
      monitor developed by Withings as a diagnostic tool for cardiovascular disorders.

      The detection of cardiovascular disorders is oriented along three axes, namely the
      measurement of blood pressure, the identification of rhythm disorders such as atrial
      fibrillation and the identification of heart murmur indicating valvular heart disease.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 13, 2019</start_date>
  <completion_date type="Actual">June 13, 2019</completion_date>
  <primary_completion_date type="Actual">June 13, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>BP precision and accuracy</measure>
    <time_frame>1 visit (45 minutes)</time_frame>
    <description>mean error and standard deviation on measurements, and standard deviation on patients (criteria 1 and 2 of ANSI/AAMI/ISO 81060-2:2013) against sphygmomanometer dual observer auscultation</description>
  </primary_outcome>
  <primary_outcome>
    <measure>AF and SR classification accuracy</measure>
    <time_frame>1 visit (30 minutes)</time_frame>
    <description>sensitivity and specificity of detection of AF and SR from 1-lead ECG against 12-lead ECG</description>
  </primary_outcome>
  <primary_outcome>
    <measure>VHD detection accuracy</measure>
    <time_frame>1 visit (30 minutes)</time_frame>
    <description>sensitivity and specificity of detection of VHD from phonocardiogram against Doppler echocardiogram</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>safety evaluation</measure>
    <time_frame>1 visit (1 hour)</time_frame>
    <description>frequency of adverse events</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">218</enrollment>
  <condition>Atrial Fibrillation</condition>
  <condition>Hypertension</condition>
  <condition>Valvular Heart Disease</condition>
  <arm_group>
    <arm_group_label>Blood pressure (BP)</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Group for the validation of blood pressure measurement by the device</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Atrial fibrillation (AF)</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Group for the validation of detection of AF by the device</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Valvular heart disease (VHD)</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Group for the validation of detection of VHD by the device</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>BP measurement</intervention_name>
    <description>sequential BP measurement with Withings WPM04 and sphygmomanometer with dual observer auscultation</description>
    <arm_group_label>Blood pressure (BP)</arm_group_label>
    <arm_group_label>Valvular heart disease (VHD)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>AF detection</intervention_name>
    <description>single lead ECG with Withings WPM04 and 12 lead ECG</description>
    <arm_group_label>Atrial fibrillation (AF)</arm_group_label>
    <arm_group_label>Valvular heart disease (VHD)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>VHD detection</intervention_name>
    <description>phonocardiogram with digital stethoscope of Withings WPM04 and Doppler echocardiography</description>
    <arm_group_label>Atrial fibrillation (AF)</arm_group_label>
    <arm_group_label>Blood pressure (BP)</arm_group_label>
    <arm_group_label>Valvular heart disease (VHD)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female over 18 years old,

          -  Subject who signed the consent form,

          -  Subject affiliated to a social security scheme or entitled.

        Exclusion Criteria:

          -  Underage subject;

          -  Subject who refused to participate in the study;

          -  Subject participating in other research or clinical studies;

          -  Subject with body mass index greater than 35 kg/m2;

          -  Subject in linguistic or psychic incapacity to sign an informed consent;

          -  Subject with congenital cardiomyopathy;

          -  Subject with aorto-venous fistula;

          -  Subject with pulmonary pathology that may degrade the quality of the recording;

          -  Subject presenting a serious pathology compromising the realization of the
             examinations envisaged in the test;

          -  Subject with an arm injury incompatible with the use of an armband sphygmomanometer;

          -  Subject receiving an intravenous perfusion on the left arm;

          -  Subject with electrical stimulation by pacemaker, implantable
             cardioverter-defibrillator;

          -  Subject with prosthetic heart valve;

          -  Subject under kidney dialysis;

          -  Hemodynamically unstable subject (acute heart failure or cardiac assistance).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Clinique AXIUM Centre de cardiologie</name>
      <address>
        <city>Aix-en-Provence</city>
        <zip>13090</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>July 19, 2019</study_first_submitted>
  <study_first_submitted_qc>July 19, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 24, 2019</study_first_posted>
  <last_update_submitted>August 2, 2019</last_update_submitted>
  <last_update_submitted_qc>August 2, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 5, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>blood pressure</keyword>
  <keyword>Arrhythmias, Cardiac</keyword>
  <keyword>atrial fibrillation</keyword>
  <keyword>valvular disease</keyword>
  <keyword>blood pressure monitors</keyword>
  <keyword>electrocardiography</keyword>
  <keyword>Doppler echocardiography</keyword>
  <keyword>Heart diseases</keyword>
  <keyword>Cardiovascular diseases</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Heart Valve Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

